Table III.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Variables | Hazard ratio | 95% CI | P-value | Hazard ratio | 95% CI | P-value |
Gender | ||||||
Male vs. female | 1.330 | 0.742–2.742 | 0.338 | – | – | – |
Age, years | ||||||
≥60 vs. <60 | 1.367 | 0.695–2.695 | 0.365 | – | – | – |
Depth of invasion | ||||||
T3/4 vs. T1/2 | 17.687 | 2.439–128.439 | 0.004 | 5.650 | 0.746–42.746 | 0.094 |
Lymph node metastasis | ||||||
Present vs. absent | 6.383 | 2.979–13.979 | <0.001 | 3.038 | 1.292–7.292 | 0.011 |
Tumor location | ||||||
Rectum vs. colon | 1.513 | 0.851–2.851 | 0.158 | – | – | – |
Lymphatic invasion | ||||||
Present vs. absent | 3.307 | 1.849–5.849 | <0.001 | 1.604 | 0.834–3.834 | 0.157 |
Venous invasion | ||||||
Present vs. absent | 1.601 | 0.827–3.827 | 0.163 | – | – | – |
Liver metastasis | ||||||
Present vs. absent | 7.258 | 4.033–13.033 | <0.001 | 4.695 | 2.511–8.511 | <0.001 |
Histological type | ||||||
Moderate and poor vs. well | 2.045 | 0.955–4.955 | 0.066 | – | – | – |
Tumor diameter, cm | ||||||
≤5 vs. >5 | 2.191 | 1.236–3.236 | 0.007 | 1.225 | 0.677–2.677 | 0.502 |
IGF-1 expression level | ||||||
High vs. low | 1.340 | 0.754–2.754 | 0.319 | – | – | – |
IGF-2 expression level | ||||||
High vs. low | 1.645 | 0.914–2.914 | 0.097 | – | – | – |
IGF-1R expression level | ||||||
High vs. low | 1.130 | 0.635–2.635 | 0.677 | – | – | – |
IGFBP-3 expression level | ||||||
High vs. low | 2.439 | 1.320–4.320 | 0.004 | 2.033 | 1.087–3.087 | 0.026 |
IGF-1, insulin-like growth factor type 1; IGF-1R, IGF receptor type 1; IGFBP-3, IGF binding protein type 3; CI, confidence interval.